(Q45163572)

10 December 2017

Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia (English)

1 reference

obsessive-compulsive disorder

10 December 2017

1 reference

1 reference

Masayuki Ohta

1

1 reference

PubMed ID

12519457

10 December 2017

Masahiro Kokai

series ordinal

2

1 reference

PubMed ID

12519457

10 December 2017

Yoshio Morita

series ordinal

3

1 reference

10 December 2017

1 February 2003

1 reference

Psychiatry and Clinical Neurosciences

10 December 2017

1 reference

10 December 2017

57

1 reference

10 December 2017

1

1 reference

10 December 2017

67-74

1 reference

Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study.

10 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Obsessive-compulsive disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: an EEG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2003.01081.X

10.1046/J.1440-1819.2003.01081.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

12519457